ITL Group returns to MEDICA 2017 to discuss future of diagnostic devices

Leading medical device design and manufacturing company, ITL Group returns to the MEDICA tradeshow in Düsseldorf, Germany this November with a simple message – ‘your future rests with us.’

ITL is an experienced full-service subcontract company, celebrating 40 years in the medical and diagnostic sector this year. Their portfolio includes in-vitro diagnostics (IVD), point-of-care devices, cancer staging and treatment, surgical robots and next-generation DNA sequencing.

The company is in excellent health in its 40th year as a full-service design and manufacturing company, with the success of its operation in the United States; continued success of the European market and rapid growth in China.

The ITL Group, which has its headquarters in Ashford, Kent returns to the World’s biggest medical technology event with a mission to showcase and discuss how its engineers are adapting existing and new technologies to develop amazing diagnostic devices that are transforming the 21st Century health-scape.

Visitors to ITL’s stand will be able to interact with the Lumipod demonstrator which encompasses a world of IVD possibilities and applications in one device.

ITL’s device employs trending technologies in the field – from near-field communication (NFC) and wireless charging to an associated tablet app and Bluetooth data transmission, to show visitors what is possible now, inviting discussions about where the industry is going next.

Greg Smith, ITL Group’s Business Director, will be leading the team attending MEDICA 2017 and is looking forward to flying the flag in Europe as a UK manufacturing company enjoying increasing international success.

He said:

We’re delighted to be back at MEDICA in our 40th year and to share with old and new partners how ITL Group is continuing to push back the boundaries of what is possible for the medical technology sector – existing and future.

We had a great reaction to our Lumipod project, last year, providing a real opportunity to start a conversation about innovation as well as showing some of the technologies our engineers are working on right now.

Technology doesn’t stand still and we’ve looking forward to showing off Mark II with the aim of encouraging people to question how they could use the technologies in their future medical devices.

ITL will be on Stand H20, in Hall 3 at MEDICA 2017. As well as demonstrating and discussing the Lumipod the team will be available to discuss new projects, staging competitions and giving visitors a chance to win free Kentish beer.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Vitl Life Science Solutions. (2019, June 19). ITL Group returns to MEDICA 2017 to discuss future of diagnostic devices. News-Medical. Retrieved on December 21, 2024 from https://www.news-medical.net/news/20171006/ITL-Group-returns-to-MEDICA-2017-to-discuss-future-of-diagnostic-devices.aspx.

  • MLA

    Vitl Life Science Solutions. "ITL Group returns to MEDICA 2017 to discuss future of diagnostic devices". News-Medical. 21 December 2024. <https://www.news-medical.net/news/20171006/ITL-Group-returns-to-MEDICA-2017-to-discuss-future-of-diagnostic-devices.aspx>.

  • Chicago

    Vitl Life Science Solutions. "ITL Group returns to MEDICA 2017 to discuss future of diagnostic devices". News-Medical. https://www.news-medical.net/news/20171006/ITL-Group-returns-to-MEDICA-2017-to-discuss-future-of-diagnostic-devices.aspx. (accessed December 21, 2024).

  • Harvard

    Vitl Life Science Solutions. 2019. ITL Group returns to MEDICA 2017 to discuss future of diagnostic devices. News-Medical, viewed 21 December 2024, https://www.news-medical.net/news/20171006/ITL-Group-returns-to-MEDICA-2017-to-discuss-future-of-diagnostic-devices.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Future opportunities explored with ITL Group's business development manager